Citius Oncology (CTOR)

• Market cap: $111M
• 1 day: -0.75%
• 5 days: -8.28%
• 1 month: -23.12%
• 3 months: -25.7%
• 6 months: 45.16%
• Year to date: 11.76%
• 1 year: 9.02%
• 5 years: -86.82%
• 10 years: -86.82%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.